Health care stocks were declining pre-bell Thursday, with The Health Care Select Sector SPDR Fund (XLV) down 0.9% and the iShares Biotechnology ETF (IBB) 0.7% lower.
Takeda Pharmaceutical (TAK) shares were down more than 0.5% after the company reported lower fiscal Q4 core earnings.
Argenx (ARGX) stock was more than 8% lower after the company posted operating income that trailed analysts' expectations.
Stevanato Group (STVN) shares were up over 1% after the company reported higher Q1 adjusted earnings and revenue.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。